Does the Beauty Health Co (SKIN) Form 4 indicate any insider share sales?

The Form 4 does not report any insider sales. It shows one acquisition transaction coded “A,” representing a grant or award of restricted stock units to the CFO, without any corresponding dispositions, tax-withholding sales, or open-market selling activity.

Beauty Health Co (NASDAQ: SKIN) CFO awarded 746,681 restricted stock units

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

MONAHAN MICHAEL P. reported acquisition or exercise transactions in this Form 4 filing.

Beauty Health Co reported that Chief Financial Officer Michael P. Monahan received a grant of 746,681 restricted stock units of Class A Common Stock. These RSUs vest in three equal annual installments starting on March 20, 2026, contingent on continued service and certain acceleration provisions. Following this award, Monahan directly holds 2,014,413 shares or share-equivalent units, reflecting a compensation-related equity grant rather than an open-market transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider MONAHAN MICHAEL P.

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	746,681	$0.00	--

Holdings After Transaction: Class A Common Stock — 2,014,413 shares (Direct)

Footnotes (1)

[object Object]

Form 4 Insider Transactions: What Each Field Means →

03/24/2026 - 05:05 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MONAHAN MICHAEL P.

(Last)

(First)

(Middle)

C/O THE BEAUTY HEALTH COMPANY

3600 E. BURNETT STREET

(Street)

LONG BEACH

CALIFORNIA

90815

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Beauty Health Co [ SKIN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	03/20/2026		A⁽¹⁾		746,681	A	⁽¹⁾	2,014,413	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock of The Beauty Health Company (the "Company"). The RSUs are subject to time-vesting conditions. The RSUs vest in one-third increments on each of the first three anniversaries of the grant date of March 20, 2026, in each case subject to continued service with the Company through the vesting date and certain acceleration rights.

Remarks:

	/s/ Paul Bokota, Attorney-in-fact for Michael Monahan	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Beauty Health Co (SKIN) disclose for Michael P. Monahan?

Beauty Health Co disclosed that CFO Michael P. Monahan received a grant of 746,681 restricted stock units of Class A Common Stock. This is a compensation-related equity award rather than an open-market trade and increases his equity-linked stake in the company.

How many RSUs did the CFO of Beauty Health Co (SKIN) receive and at what price?

The CFO received 746,681 restricted stock units, each representing one share of Class A Common Stock, at a grant price of $0.00 per unit. This reflects a non-cash equity compensation grant, typical for senior executives instead of an open-market purchase.

What are the vesting terms of the RSU grant reported by Beauty Health Co (SKIN)?

The RSUs vest in one-third increments on each of the first three anniversaries of the grant date, starting March 20, 2026. Vesting requires continued service with Beauty Health Co and is also subject to certain acceleration rights described in the award terms.

What is the CFO’s total equity position after this Form 4 at Beauty Health Co (SKIN)?

After the RSU grant, the CFO is reported as directly holding 2,014,413 shares or share-equivalent units of Class A Common Stock. This total includes the newly granted restricted stock units, which will deliver shares only as they vest over time.